Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 12/20 | 0.55 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.39 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Beauvericin SCHEMBL22510041 | 1.00 | ABCB1 (0.55) | ABCB1CAPN1HDAC6GFERCES2 | |
| Beauvericin SCHEMBL6452789 | 1.00 | ABCB1 (0.55) | ABCB1CAPN1HDAC6GFERCES2 | |
| Beauvericin SCHEMBL16218239 | 1.00 | ABCB1 (0.55) | ABCB1CAPN1HDAC6GFERCES2 | |
| SCHEMBL30932793 | 1.00 | ABCB1 (0.55) | ABCB1CAPN1HDAC6GFERCES2 | |
| SCHEMBL29519838 | 1.00 | ABCB1 (0.55) | ABCB1CAPN1HDAC6GFERCES2 | |
| SCHEMBL17520706 | 0.94 | ABCB1 (0.53) | ABCB1CAPN1HDAC6GFER | |
| SCHEMBL17520687 | 0.94 | ABCB1 (0.53) | ABCB1CAPN1HDAC6GFER | |
| SCHEMBL17520688 | 0.94 | ABCB1 (0.53) | ABCB1CAPN1HDAC6GFER | |
| Beauvericin A SCHEMBL30278897 | 0.92 | ABCB1 (0.49) | ABCB1HDAC6MMP1MMP3MMP9 | |
| SCHEMBL30278900 | 0.92 | ABCB1 (0.49) | ABCB1HDAC6MMP1MMP3MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 13337 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125721-A1 | ACIDOPHILIC FUSARIUM OXYSPORUM STRAINS, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | THE FYNDER GROUP, INC. | 2026-05-07 | — | — | US | claimed |
| US-12612593-B2 | Food materials comprising filamentous fungal particles and membrane bioreactor design | THE FYNDER GROUP, INC. (US) | 2026-04-28 | — | — | US | claimed |
| WO-2026043908-A1 | COMPOSITIONS AND METHODS TO IMPROVE SEQUESTRATION OF MYCOTOXINS AND THEIR USE IN DETOXIFICATION OF ANIMAL FEED AND ANIMAL PRODUCTION SYSTEMS | ALLTECH, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| EP-4684795-A1 | USE OF BEAUVERICIN IN PREPARATION OF DRUG FOR INHIBITING ANGIOGENESIS | Zih Yuan Tang Biotechnology Co., Ltd. (TW) | 2026-01-28 | — | — | EP | claimed |
| EP-3946414-B1 | BEAUVERICIN FOR TREATING OCULAR DISEASES | ZIH YUAN TANG BIOTECHNOLOGY CO LTD (TW) | 2025-12-03 | — | — | EP | claimed |
| US-12344878-B2 | Artificial organelles for enzymatic cofactor reduction | ENSOVI, INC. (US) | 2025-07-01 | — | — | US | claimed |
| CN-120118930-A | Beauverine synthesis regulation related application of gene PP558224 | 浙江省亚热带作物研究所(浙南林业科学研究院) | 2025-06-10 | — | — | CN | claimed |
| CN-119015397-B | Beauverine composition for inhibiting proliferation of human prostate cancer cells and preparation method thereof | 广州医科大学附属中医医院(广州市中医中药研究所、广州市中医医院、广州中医药大学附属广州中医医院、广州市针灸医院) | 2025-04-18 | — | — | CN | claimed |
| CN-113795268-B | Method for treating eye diseases | 资元堂生物科技股份有限公司 | 2025-04-08 | — | — | CN | claimed |
| WO-2025059358-A1 | FUNGAL STRAINS HAVING REDUCED OR ELIMINATED MYCOTOXIN, ETHANOL, AND/OR PIGMENT PRODUCTION CAPACITY | THE FYNDER GROUP, INC. (US) | 2025-03-20 | — | — | WO | claimed |
| US-6117668-A | BACTERIUM WHICH DEGRADES FUNGAL TOXIN; FOR THE DEGRADATION FUNGAL TOXIN IN PLANTS; FOR PREPARATION OF NONCONTAMINATED FOOD GRAINS AND FEEDS | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2000-09-12 | — | — | US | claimed |
| CN-1264541-A | 7% stellerin-aconitine-beauvericin suspension and preparing process thereof | LI JUN (CN) | 2000-08-30 | — | — | CN | claimed |
| EP-0938576-A1 | BEAUVERICIN DETOXIFICATION COMPOSITIONS AND METHODS | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 1999-09-01 | — | — | EP | claimed |
| EP-0511273-B1 | LIPOSOMES AS CONTRAST AGENTS FOR ULTRASONIC IMAGING | IMARX PHARMACEUTICAL CORP (US) | 1999-05-19 | — | — | EP | claimed |
| WO-1998022603-A1 | BEAUVERICIN DETOXIFICATION COMPOSITIONS AND METHODS | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 1998-05-28 | — | — | WO | claimed |
| US-5352435-A | Ionophore containing liposomes for ultrasound imaging | CITIZENS BANK, N.A. | 1994-10-04 | — | — | US | claimed |
| EP-0511273-A4 | LIPOSOMES AS CONTRAST AGENTS FOR ULTRASONIC IMAGING | — | 1993-03-31 | — | — | EP | claimed |
| EP-0511273-A1 | LIPOSOMES AS CONTRAST AGENTS FOR ULTRASONIC IMAGING | IMARX PHARMACEUTICAL CORP. (US) | 1992-11-04 | — | — | EP | claimed |
| US-5088499-A | Medical diagnosis | CITIZENS BANK, N.A. | 1992-02-18 | — | — | US | claimed |
| WO-1991009629-A1 | LIPOSOMES AS CONTRAST AGENTS FOR ULTRASONIC IMAGING | UNGER EVAN C (US) | 1991-07-11 | — | — | WO | claimed |